Peptide Pharmaceuticals: Opportunities, Prospects, and Limitations


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Currently, a number of peptide pharmaceuticals are widely used in medical practice, but the market size of such drugs remains relatively small. However, in the coming years, one can expect a significant increase in interest in peptide pharmaceuticals, which is primarily due to their low toxicity and wide range of possible molecular targets. The results obtained in recent years allow us to take a new approach to the development of such drugs, which will make it possible to expand the range of possible applications of peptide drugs and improve their efficiency and usability.

Sobre autores

P. Slominsky

Institute of Molecular Genetics

Email: shadrina@img.ras.ru
Rússia, Moscow, 123182

M. Shadrina

Institute of Molecular Genetics

Autor responsável pela correspondência
Email: shadrina@img.ras.ru
Rússia, Moscow, 123182

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Allerton Press, Inc., 2018